Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Neoplasms 1Muscle Invasive Bladder Cancer 1Laryngeal Neoplasms 1Laryngeal Diseases 1Inoperable œsophageal Cancer 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 11Cetuximab 10Radiotherapy 7Fluorouracil 6Docetaxel 5pembrolizumab 4Carboplatin 4figitumumab 3Radiation 3Paclitaxel 3Erlotinib Hydrochloride 3Bleomycin 3130-nm albumin-bound paclitaxel 3talimogene laherparepvec 2avelumab 2Surgical Procedures, Operative 2Oxaliplatin 2Lapatinib 2Capecitabine 2zalutumumab 1yeast-CEA vaccine 1temsirolimus 1temoporfin 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1selinexor 1remetinostat 1ponatinib 1patritumab 1nilotinib 1necitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Squamous Cell × Chemoradiotherapy × Clear all
NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡